Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

CDRH Strategic Plan Calls For Database To Identify 'Compliance Targets'

This article was originally published in The Silver Sheet

Executive Summary

A DATABASE THAT WILL HELP FDA PINPOINT 'COMPLIANCE TARGETS' is among the action items included in CDRH's 2010 Compliance Strategic Plan. "We want to use data from databases that are maintained within the agency and possibly data outside the agency to help us develop a risk profile of particular firms," says Steve Silverman, senior advisor to CDRH Director Jeffrey Shuren. The database could enhance FDA's risk-based inspection approach, which allows compliance officers to decide which types of devices and facilities to focus on each year based on the likelihood of manufacturing or safety problems. The strategic plan also calls for a tighter relationship between CDRH and FDA's Office of Regulatory Affairs, as well as mechanisms to deliver warning letters to manufacturers faster

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

MT036500

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel